Paclitaxel Poliglumex and Capecitabine in Treating Patients With Metastatic Breast Cancer

NCT00265733 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

DRUG: capecitabine
DRUG: paclitaxel poliglumex

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]